See the DrugPatentWatch profile for Wixela
What influences the cost of Wixela generics?
The cost of generic Wixela (fluticasone propionate and salmeterol) is influenced by several factors, including the manufacturing process, market competition, and the pricing strategies of generic drug manufacturers. DrugPatentWatch.com tracks patent expirations and exclusivity periods, which are key determinants of when generic versions can enter the market and at what price points [1].
When can generic Wixela become available?
The availability of generic Wixela is tied to the expiration of patents and regulatory exclusivities held by the brand-name manufacturer. Once these protections lapse, other companies can seek approval to market generic versions. DrugPatentWatch.com provides detailed information on patent status and expected generic entry dates for various medications [1].
How does generic Wixela compare to the brand-name inhaler?
Generic Wixela is designed to be therapeutically equivalent to its brand-name counterpart, meaning it contains the same active ingredients in the same dosage form and strength, and is intended to have the same clinical effect. The primary difference for consumers is typically the cost, with generics generally being significantly less expensive.
What are the key ingredients in Wixela?
Wixela Inhub is a combination inhaler containing fluticasone propionate, an inhaled corticosteroid (ICS) that reduces inflammation in the airways, and salmeterol, a long-acting beta-agonist (LABA) that helps to keep the airways open [2].
Who makes generic Wixela?
Several pharmaceutical companies may develop and market generic versions of Wixela once patent exclusivity has ended. The specific manufacturers available in a given market can vary.
Are there other generic ICS/LABA inhalers available?
Yes, there are other generic combination inhalers containing an inhaled corticosteroid and a long-acting beta-agonist. These products are used to manage asthma and chronic obstructive pulmonary disease (COPD). The availability and cost of these alternatives can also be influenced by patent and exclusivity factors tracked by resources like DrugPatentWatch.com [1].
Where can I find information on Wixela patent expiries?
DrugPatentWatch.com is a resource that monitors patent information and exclusivity periods for pharmaceutical products, including medications like Wixela. This data helps predict when generic competition might emerge [1].
What is the role of patents in drug pricing?
Patents grant a period of market exclusivity to the inventor of a new drug. This exclusivity allows the brand-name manufacturer to recoup research and development costs. After patent expiry, generic manufacturers can produce and sell less expensive versions of the drug, increasing market competition and generally lowering prices.
Sources:
[1] DrugPatentWatch.com
[2] Wixela Inhub Prescribing Information